Your browser doesn't support javascript.
loading
Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3.
Villegas, Florian; Lehalle, Daphné; Mayer, Daniela; Rittirsch, Melanie; Stadler, Michael B; Zinner, Marietta; Olivieri, Daniel; Vabres, Pierre; Duplomb-Jego, Laurence; De Bont, Eveline S J M; Duffourd, Yannis; Duijkers, Floor; Avila, Magali; Geneviève, David; Houcinat, Nada; Jouan, Thibaud; Kuentz, Paul; Lichtenbelt, Klaske D; Thauvin-Robinet, Christel; St-Onge, Judith; Thevenon, Julien; van Gassen, Koen L I; van Haelst, Mieke; van Koningsbruggen, Silvana; Hess, Daniel; Smallwood, Sebastien A; Rivière, Jean-Baptiste; Faivre, Laurence; Betschinger, Joerg.
Afiliação
  • Villegas F; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; Faculty of Sciences, University of Basel, 4003 Basel, Switzerland.
  • Lehalle D; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Mayer D; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; Faculty of Sciences, University of Basel, 4003 Basel, Switzerland.
  • Rittirsch M; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
  • Stadler MB; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.
  • Zinner M; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; Faculty of Sciences, University of Basel, 4003 Basel, Switzerland.
  • Olivieri D; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
  • Vabres P; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France; D
  • Duplomb-Jego L; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • De Bont ESJM; Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University Medical Centre Groningen, Groningen, the Netherlands.
  • Duffourd Y; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Duijkers F; Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Avila M; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Geneviève D; Department of Clinical Genetics, University Medical Centre Montpellier, Montpellier, France.
  • Houcinat N; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Jouan T; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Kuentz P; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Lichtenbelt KD; Department of Genetics, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.
  • Thauvin-Robinet C; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • St-Onge J; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Thevenon J; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • van Gassen KLI; Department of Genetics, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.
  • van Haelst M; Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Koningsbruggen S; Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Hess D; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
  • Smallwood SA; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
  • Rivière JB; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada; Department of Human Genetics, Faculty of Medicine, McGill U
  • Faivre L; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon et Université de Bourgogne, 21079 Dijon, France; Equipe GAD, INSERM LNC UMR 1231, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Betschinger J; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland. Electronic address: joerg.betschinger@fmi.ch.
Cell Stem Cell ; 24(2): 257-270.e8, 2019 02 07.
Article em En | MEDLINE | ID: mdl-30595499
ABSTRACT
Self-renewal and differentiation of pluripotent murine embryonic stem cells (ESCs) is regulated by extrinsic signaling pathways. It is less clear whether cellular metabolism instructs developmental progression. In an unbiased genome-wide CRISPR/Cas9 screen, we identified components of a conserved amino-acid-sensing pathway as critical drivers of ESC differentiation. Functional analysis revealed that lysosome activity, the Ragulator protein complex, and the tumor-suppressor protein Folliculin enable the Rag GTPases C and D to bind and seclude the bHLH transcription factor Tfe3 in the cytoplasm. In contrast, ectopic nuclear Tfe3 represses specific developmental and metabolic transcriptional programs that are associated with peri-implantation development. We show differentiation-specific and non-canonical regulation of Rag GTPase in ESCs and, importantly, identify point mutations in a Tfe3 domain required for cytoplasmic inactivation as potentially causal for a human developmental disorder. Our work reveals an instructive and biomedically relevant role of metabolic signaling in licensing embryonic cell fate transitions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Diferenciação Celular / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Lisossomos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Diferenciação Celular / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Lisossomos Idioma: En Ano de publicação: 2019 Tipo de documento: Article